Association between prognostic biomarkers of CyclinD1 and estrogen receptor in breast cancer by immunohistochemical analysis

Breast cancer is the most common malignant tumour & the leading cause of cancer death in women worldwide annually. Invasive duct carcinoma of the breast is a clinically and biologically heterogeneous disease. A cross–sectional study was carried out among 40 cases of formalin fixed, paraffin embe...

Full description

Bibliographic Details
Main Authors: Aung, Sanda, Aung, Tha
Format: Proceeding Paper
Language:English
Published: 2013
Subjects:
Online Access:http://irep.iium.edu.my/31897/1/1568.pdf_print.pdf
_version_ 1825647456697712640
author Aung, Sanda
Aung, Tha
author_facet Aung, Sanda
Aung, Tha
author_sort Aung, Sanda
collection IIUM
description Breast cancer is the most common malignant tumour & the leading cause of cancer death in women worldwide annually. Invasive duct carcinoma of the breast is a clinically and biologically heterogeneous disease. A cross–sectional study was carried out among 40 cases of formalin fixed, paraffin embedded tissue sections of invasive duct carcinoma (NST) of the breast. Histological grading was done according to Modified Bloom and Richardson Grading. Immunoexpression of cyclinD1 (using DAKO M7155) and ER (using DAKO M7047) were detected by immunohistochemistry. In this study, at least 10% of brown nuclear staining regardless of staining intensity was interpreted as positive. The data was analysed by using chi- square test. (SPSS version 11.5) . In 40 patients, the ages ranged from 34 to 78 years with a mean of 54 years. CyclinD1 expression was detected in 43% (17 of 40) of cases, and was inversely associated with histological grade (p=0.01). ER immunoreactivity was found in 30% (12 of 40) of patients and was inversely associated with histological grade (p=0.021). CyclinD1 immunoreactivity was positively associated with estrogen receptor expression (p=0.043). There was no significant correlation with clinical prognostic parameters of age, menopausal status, tumour size and clinical stage with both prognostic biomarkers.
first_indexed 2024-03-05T23:17:53Z
format Proceeding Paper
id oai:generic.eprints.org:31897
institution International Islamic University Malaysia
language English
last_indexed 2024-03-05T23:17:53Z
publishDate 2013
record_format dspace
spelling oai:generic.eprints.org:318972013-09-13T01:54:28Z http://irep.iium.edu.my/31897/ Association between prognostic biomarkers of CyclinD1 and estrogen receptor in breast cancer by immunohistochemical analysis Aung, Sanda Aung, Tha RB Pathology Breast cancer is the most common malignant tumour & the leading cause of cancer death in women worldwide annually. Invasive duct carcinoma of the breast is a clinically and biologically heterogeneous disease. A cross–sectional study was carried out among 40 cases of formalin fixed, paraffin embedded tissue sections of invasive duct carcinoma (NST) of the breast. Histological grading was done according to Modified Bloom and Richardson Grading. Immunoexpression of cyclinD1 (using DAKO M7155) and ER (using DAKO M7047) were detected by immunohistochemistry. In this study, at least 10% of brown nuclear staining regardless of staining intensity was interpreted as positive. The data was analysed by using chi- square test. (SPSS version 11.5) . In 40 patients, the ages ranged from 34 to 78 years with a mean of 54 years. CyclinD1 expression was detected in 43% (17 of 40) of cases, and was inversely associated with histological grade (p=0.01). ER immunoreactivity was found in 30% (12 of 40) of patients and was inversely associated with histological grade (p=0.021). CyclinD1 immunoreactivity was positively associated with estrogen receptor expression (p=0.043). There was no significant correlation with clinical prognostic parameters of age, menopausal status, tumour size and clinical stage with both prognostic biomarkers. 2013-02-19 Proceeding Paper PeerReviewed application/pdf en http://irep.iium.edu.my/31897/1/1568.pdf_print.pdf Aung, Sanda and Aung, Tha (2013) Association between prognostic biomarkers of CyclinD1 and estrogen receptor in breast cancer by immunohistochemical analysis. In: IIUM Research, Invention and Innovation Exhibition (IRIIE) 2013, 19-20th February 2013, Cultural Activity Centre (CAC) and KAED Gallery, IIUM. http://www.iium.edu.my/irie/13/info/IRIIE-2013-Abstact-Category.pdf
spellingShingle RB Pathology
Aung, Sanda
Aung, Tha
Association between prognostic biomarkers of CyclinD1 and estrogen receptor in breast cancer by immunohistochemical analysis
title Association between prognostic biomarkers of CyclinD1 and estrogen receptor in breast cancer by immunohistochemical analysis
title_full Association between prognostic biomarkers of CyclinD1 and estrogen receptor in breast cancer by immunohistochemical analysis
title_fullStr Association between prognostic biomarkers of CyclinD1 and estrogen receptor in breast cancer by immunohistochemical analysis
title_full_unstemmed Association between prognostic biomarkers of CyclinD1 and estrogen receptor in breast cancer by immunohistochemical analysis
title_short Association between prognostic biomarkers of CyclinD1 and estrogen receptor in breast cancer by immunohistochemical analysis
title_sort association between prognostic biomarkers of cyclind1 and estrogen receptor in breast cancer by immunohistochemical analysis
topic RB Pathology
url http://irep.iium.edu.my/31897/1/1568.pdf_print.pdf
work_keys_str_mv AT aungsanda associationbetweenprognosticbiomarkersofcyclind1andestrogenreceptorinbreastcancerbyimmunohistochemicalanalysis
AT aungtha associationbetweenprognosticbiomarkersofcyclind1andestrogenreceptorinbreastcancerbyimmunohistochemicalanalysis